Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →🤖 ML Fraud Detection Score: 84%
Machine learning model identifies prescribing patterns consistent with confirmed fraud cases. This is a statistical indicator, not an accusation.
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
8,652
Total Claims
$1.4M
Drug Cost
362
Beneficiaries
$3,968
Cost/Patient
Risk Score Breakdown 62/100
Score components are additive. Read full methodology
Peer Comparison vs. 218,535 Nurse Practitioner providers
+1364%
Opioid rate vs peers
55.4% vs 3.8% avg
+238%
Cost per patient vs peers
$3,968 vs $1,174 avg
+44%
Brand preference vs peers
12.7% vs 8.9% avg
⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
55.4%
Opioid Rate
4,791
Opioid Claims
$590K
Opioid Cost
31.7%
Long-Acting Rate
This provider's opioid prescribing rate of 55.4% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 1,102 claims · $1.0M
Generic: 7,550 claims · $394K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Oxycodone Hcl | 333 | $259K |
| Methylnaltrexone Bromide | 55 | $243K |
| Diclofenac Sodium | 129 | $141K |
| Rimegepant Sulfate | 49 | $76K |
| Oxycodone Myristate | 102 | $76K |
| Oxycodone Hcl | 1,993 | $71K |
| Lidocaine | 65 | $66K |
| Diclofenac Sodium | 14 | $51K |
| Erenumab-Aooe | 35 | $39K |
| Lidocaine | 144 | $30K |
| Morphine Sulfate | 719 | $27K |
| Hydrocodone Bitartrate | 38 | $26K |
| Buprenorphine Hcl | 27 | $23K |
| Fentanyl | 142 | $20K |
| Hydrocodone/Acetaminophen | 468 | $18K |
Prescribing Profile
62
Unique Drugs
62.0
Anomaly Score
Patient Profile
65
Avg Age
61%
Female
1.53
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About